Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zesty Paws is a leading pet health and wellness company specializing in premium functional supplements for dogs and cats. Founded in 2014 and headquartered in Orlando, Florida, the company provides a wide range of soft chew supplements targeting specific health concerns such as joint support, gut health, skin and coat condition, and behavioral issues. Zesty Paws utilizes high-quality, branded ingredients like OptiMSM and DE111 probiotic to ensure efficacy and safety for pets. In 2021, the company was acquired by the Health & Happiness (H&H) Group for $610 million, further expanding its global reach in the pet nutraceutical market. The brand is highly recognized for its strong e-commerce presence and consistently high customer ratings on platforms like Amazon and Chewy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zesty Paws.